TEZCAT BIOSCIENCES
  • Home
  • About
  • Team
  • Contact
 About Tezcat Biosciences:
Tezcat Biosciences is developing a RAS Therapeutic Discovery Platform to unlock the full potential of druggable targets. Tezcat combines validated discovery tools and their proprietary enabling technology to create new therapies.​ The Discovery Platform is scalable, as it can be applied to context-dependent iterations and various indications to support both internal R&D and strategic partnerships. 
​
Born out of NYU Langone Health, our team is committed to refining and delivering the leading-edge technology from bench to bedside. Tezcat Biosciences has participated in the following programs:
  • 2021 TMC Accelerator for Cancer Therapeutics, part of TMC Innovation and funded by Cancer Prevention and Research Institute of Texas (CPRIT)
  • 2020 JLABs Virtual Program, part of Johnson & Johnson Innovation
  • 2018 Entrepreneurship Lab (ELab) Program, an initiative of NYC's Economic Development Corporation (NYCEDC).
Copyright © 2022, Tezcat Biosciences, All Rights Reserved
  • Home
  • About
  • Team
  • Contact